Spots Global Cancer Trial Database for cancer of pancreas
Every month we try and update this database with for cancer of pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | NCT03347162 | Cancer Cancer of Pancr... Cancer of Liver Cancer of Esoph... Cancer of Stoma... Cancer, Metasta... | 18 Years - | Rigshospitalet, Denmark | ||
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors | NCT05361954 | Cancer Cancer of Pancr... Sarcoma Hepatic Metasta... Solid Tumor | STI-1386 | 18 Years - | Sorrento Therapeutics, Inc. | |
A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients | NCT02442323 | Cancer of Pancr... | Walking Interve... | 18 Years - | Fox Chase Cancer Center | |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | NCT03452774 | Cancer, Metasta... Cancer Cancer of Pancr... Cancer of Liver Cancer of Stoma... Cancer Liver Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Cervi... Cancer of Colon Cancer of Laryn... Cancer, Lung Cancer, Breast Cancer, Advance... Cancer Prostate Cancer of Neck Cancer of Skin Neuroendocrine ... Carcinoma Mismatch Repair... BRCA Gene Rearr... Non Hodgkin Lym... Leukemia Non Small Cell ... Cholangiocarcin... Glioblastoma Central Nervous... Melanoma Urothelial Carc... Bladder Cancer Ovarian Cancer Endometrial Can... Testicular Canc... Breast Cancer COVID Myelofibrosis Myeloproliferat... Myeloproliferat... Follicular Lymp... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... | Clinical Trial ... | - | Massive Bio, Inc. | |
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer | NCT04128332 | Cancer of Pancr... | Pre-operative s... | 16 Years - | Cambridge University Hospitals NHS Foundation Trust | |
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors | NCT05830097 | Cancer, Breast Cancer, Lung Cancer of Pancr... Cancer of Esoph... Cancer Colorect... | CBP-1019 | 18 Years - | Coherent Biopharma (Hefei) Co., Ltd. | |
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | NCT02608229 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | BVD-523 Nab-paclitaxel Gemcitabine Tumor biopsy | 18 Years - | Washington University School of Medicine | |
Home-based Prehabilitation in Pancreatic Resection | NCT05496777 | Preoperative Ph... Aerobic Capacit... Aerobic Fitness Functional Mobi... Cancer Weight, Body Cancer of Pancr... | Home-based preh... | 18 Years - | Academisch Ziekenhuis Maastricht | |
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy | NCT01056601 | Pancreatic Canc... | Bortezomib Panobinostat | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Iconographic Registry of Pancreatobiliary Endoscopy Procedures | NCT06344507 | Pancreas Neopla... Cancer of Pancr... Pancreatitis Neuroendocrine ... | 18 Years - | IRCCS San Raffaele | ||
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly | NCT04164602 | Diabetes Mellit... Diabetes Diabetes Mellit... Diabetes type2 Cancer of Pancr... Pancreas Neopla... Pancreas Adenoc... Pancreatic Canc... | 60 Years - | University of Pecs | ||
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer | NCT02681601 | Cancer of Pancr... | Nutrawell Powde... Diet Only OmegaRich fish ... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas | NCT02682394 | Cancer of Pancr... | 18 Years - | Soroka University Medical Center | ||
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | NCT03924466 | Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer | 68GaNOTA-Anti-H... | 18 Years - | Universitair Ziekenhuis Brussel | |
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | NCT03924466 | Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer | 68GaNOTA-Anti-H... | 18 Years - | Universitair Ziekenhuis Brussel | |
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy | NCT03659292 | Cancer of Pancr... | GEA PCEA GA PCIA | 18 Years - 80 Years | Fudan University | |
Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach | NCT06316908 | Abdominal Cance... Cancer Pain Cancer of Pancr... | Unilateral Neur... Bilateral Neuro... | 20 Years - 70 Years | Sindh Institute of Urology and Transplantation | |
The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan | NCT02296736 | Cancer of Pancr... | Computerised to... | - | University Hospital Plymouth NHS Trust | |
Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer | NCT02333409 | Cancer of Pancr... Pain | Electroacupunct... | - | Chinese University of Hong Kong | |
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients | NCT06046794 | Cancer Of Pancr... | Analyze of GemC... | 18 Years - | Institut Paoli-Calmettes | |
M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas | NCT03451773 | Cancer of Pancr... Pancreas Cancer Pancreatic Aden... Pancreatic Canc... Pancreatic Neop... | M7824 Gemcitabine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations | NCT05163028 | Non Small Cell ... Colorectal Canc... Pancreatic Canc... Solid Tumor Cancer Cancer of Pancr... Cancer of Colon | HBI-2376 | 18 Years - | HUYABIO International, LLC. | |
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | NCT03607643 | Cancer of Pancr... Cancer of Liver Cancer of Rectu... Cancer of Colon Cancer, Gall Bl... Myeloma Multipl... Glioblastoma Mu... | Cannabidiol Bortezomib Leucovorin 5-FU Oxaliplatin Bevacizumab Irinotecan Gemcitabine Temozolomide | 18 Years - 80 Years | Leaf Vertical Inc. | |
The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan | NCT02296736 | Cancer of Pancr... | Computerised to... | - | University Hospital Plymouth NHS Trust | |
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | NCT02311361 | Pancreatic Neop... Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Durvalumab Tremelimumab Sterostatic bod... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Improving Goals of Care Discussion in Advanced Cancer Patients | NCT02374255 | Primary Stage I... Esophageal Colorectal Canc... Glioblastoma Cancer of Stoma... Cancer of Pancr... Melanoma Head or Neck Ca... Stage III Stage IV Lung Cancers Pancreatic Canc... | GoC interventio... | 21 Years - | Icahn School of Medicine at Mount Sinai | |
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer | NCT02681601 | Cancer of Pancr... | Nutrawell Powde... Diet Only OmegaRich fish ... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | NCT00683358 | Pancreatic Canc... Pancreas Neopla... | VEGFR1-A24-1084... | 20 Years - 85 Years | Tokyo University | |
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | NCT02352831 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Tosedostat Capecitabine Fresh tissue bi... | 18 Years - | Washington University School of Medicine | |
Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device | NCT04008537 | Cancer of Pancr... Cancer of Pelvi... Cancer of Abdom... Cancer of Thora... | Ring gantry kV-... | 18 Years - | Washington University School of Medicine | |
Early Support in Primary Care for People Starting Treatment for Cancer | NCT03719716 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... | Anticipatory ca... | 18 Years - | NHS Lothian | |
Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer | NCT02902484 | Cancer of Pancr... | Nintedanib | 18 Years - | University of Texas Southwestern Medical Center | |
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer | NCT02902484 | Cancer of Pancr... | Nintedanib | 18 Years - | University of Texas Southwestern Medical Center | |
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | NCT04123574 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreatic Canc... | Talabostat Mesy... | 18 Years - 75 Years | BioXcel Therapeutics Inc | |
Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery | NCT03245346 | Cancer of Pancr... | GEA PCEA GA PCIA | 18 Years - | Fudan University | |
Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | NCT00683085 | Pancreatic Canc... Pancreas Neopla... | HLA-A*02:01-res... | 20 Years - 85 Years | Tokyo University | |
Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | NCT02311439 | Cancer of Pancr... | FOLFIRINOX + CR... | 18 Years - 75 Years | Assiut University | |
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | NCT03347162 | Cancer Cancer of Pancr... Cancer of Liver Cancer of Esoph... Cancer of Stoma... Cancer, Metasta... | 18 Years - | Rigshospitalet, Denmark | ||
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients | NCT03278015 | Cancer of Pancr... | Nab-paclitaxel ... Gemcitabine mon... S-1 monotherapy | 18 Years - 80 Years | Chinese PLA General Hospital | |
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | NCT02608229 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | BVD-523 Nab-paclitaxel Gemcitabine Tumor biopsy | 18 Years - | Washington University School of Medicine | |
Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level | NCT04677244 | Cancer of Pancr... | Blood sample in... | 40 Years - 85 Years | Institut Paoli-Calmettes | |
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients | NCT06046794 | Cancer Of Pancr... | Analyze of GemC... | 18 Years - | Institut Paoli-Calmettes | |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars | NCT04971304 | Cancer, Breast Cancer, Lung Cancer of Colon Cancer of Pancr... Cancer, Ovarian Lymphoma, Non-H... | Receipt of gran... | 20 Years - | Biologics & Biosimilars Collective Intelligence Consortium | |
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars | NCT04971304 | Cancer, Breast Cancer, Lung Cancer of Colon Cancer of Pancr... Cancer, Ovarian Lymphoma, Non-H... | Receipt of gran... | 20 Years - | Biologics & Biosimilars Collective Intelligence Consortium | |
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer | NCT06148298 | Cancer of Pancr... | Non-Human Subje... | 18 Years - | University of Central Florida | |
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint | NCT00613730 | Cancer of Pancr... Cancer of the P... Pancreas Cancer Pancreatic Canc... | Gemcitabine panitumumab | 18 Years - 75 Years | Amgen | |
A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas | NCT05566743 | Cancer of Pancr... | Capecitabine follow up | 18 Years - 69 Years | Menoufia University | |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | NCT00690300 | Pancreas Neopla... | Docetaxel Oxaliplatin | 18 Years - | University of Ulm | |
Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy | NCT05163977 | Cancer of Pancr... | Blumgart Anasto... Cattell Warren ... | - | Cairo University | |
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer | NCT01771146 | Pancreas Cancer Localized Pancr... Non-metastatic ... | FOLFIRINOX Regi... | 18 Years - | Baylor Research Institute | |
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection | NCT03536793 | Cancer of Pancr... Pancreas Cyst | 18 Years - | Hull University Teaching Hospitals NHS Trust | ||
Epidural Analgesia Use in Pancreatic Resections | NCT02681796 | Cancer of Pancr... Cancer of the P... Pancreas Cancer Pancreas Neopla... Pancreatic Canc... | Bupivacaine | 18 Years - | Washington University School of Medicine | |
Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRI | NCT03961646 | Cancer of Pancr... | 18 Years - | Fondation Hôpital Saint-Joseph | ||
A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas | NCT05566743 | Cancer of Pancr... | Capecitabine follow up | 18 Years - 69 Years | Menoufia University | |
Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level | NCT04677244 | Cancer of Pancr... | Blood sample in... | 40 Years - 85 Years | Institut Paoli-Calmettes | |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | NCT03977233 | Pancreatic Duct... Cancer of Pancr... Pancreatic Canc... Pancreas Adenoc... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Oxaliplatin Leucovorin Irinotecan Hydr... 5-FU | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
Early Support in Primary Care for People Starting Treatment for Cancer | NCT03719716 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... | Anticipatory ca... | 18 Years - | NHS Lothian | |
Effects of Dexmedetomidine During IRE Procedures for Solid Tumours | NCT02044224 | Cancer of Liver Cancer of Pancr... | Dexmedetomidine | 18 Years - 85 Years | Uppsala University Hospital | |
Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899636 | Stage III Pancr... | Modified FOLFIR... NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device | NCT04008537 | Cancer of Pancr... Cancer of Pelvi... Cancer of Abdom... Cancer of Thora... | Ring gantry kV-... | 18 Years - | Washington University School of Medicine | |
Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer | NCT04049461 | Cancer of Pancr... Ossification, H... | Bone alkaline p... Abdominal CT sc... | 18 Years - 80 Years | Nanjing Medical University | |
Enteral Nutrition After Pancreaticoduodenectomy | NCT03150615 | Cancer of Pancr... Cancer of Duode... Ampulla of Vate... Cholangiocarcin... | Early enteral n... Saline nasojejunal tub... Oral intake | 18 Years - 80 Years | Nanjing Medical University | |
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | NCT02905578 | Pancreatic Neop... Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... Adenocarcinoma | Gemcitabine nab-paclitaxel Pharmacological... | 18 Years - | University of Iowa | |
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy | NCT04809935 | Cancer of Pancr... Pancreatic Neop... Pain Cancer-Associat... Pain Management | 98% dehydrated ... 19G EUSRA needl... | 18 Years - | The University of Hong Kong | |
Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer | NCT04049461 | Cancer of Pancr... Ossification, H... | Bone alkaline p... Abdominal CT sc... | 18 Years - 80 Years | Nanjing Medical University | |
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy | NCT04809935 | Cancer of Pancr... Pancreatic Neop... Pain Cancer-Associat... Pain Management | 98% dehydrated ... 19G EUSRA needl... | 18 Years - | The University of Hong Kong | |
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | NCT03899649 | Stage III Pancr... | SOC NanoKnife Syste... | 18 Years - | Angiodynamics, Inc. | |
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer | NCT03649321 | Cancer of Pancr... | Bemcentinib Nab-paclitaxel Gemcitabine Cisplatin | 18 Years - | University of Texas Southwestern Medical Center | |
Trial Comparing 19 and 25-gauge EUS-FNA Needles | NCT01677312 | Cancer of Pancr... Pancreatic Neop... | Pancreatic Biop... Histological Sa... | 19 Years - | AdventHealth | |
Diet and Exercise After Pancreatic Cancer | NCT03187028 | Pancreatic Canc... | Diet Only Diet + Exercise | 18 Years - | University of Alabama at Birmingham | |
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | NCT02311361 | Pancreatic Neop... Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Durvalumab Tremelimumab Sterostatic bod... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) |